DVM

DSC Securities purchased over 4.6 million DVM shares on April 14-15, lifting its ownership from 4.05% to 13.9% and becoming a major shareholder of Vietnam Medicinal Materials Corporation (DVM). The move follows a similar stake-building in Vidipha (VDP) in late 2025, signaling DSC's strategic interest in the pharmaceutical sector.